Treatment optimization in multiple sclerosis: how do we apply emerging evidence?
Author:
Affiliation:
1. MS Center Dresden, Center of Clinical Neuroscience, University Clinic Carl Gustav Carus, Dresden University of Technology, Dresden, Germany
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2017.1292135
Reference27 articles.
1. Optimizing treatment success in multiple sclerosis
2. Optimizing therapy early in multiple sclerosis: An evidence-based view
3. Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
4. Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach
5. Using MRI to make informed clinical decisions in multiple sclerosis care
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial;BMC Neurology;2022-11-12
2. A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis;Brain Sciences;2021-09-03
3. An ID-Associated Application to Facilitate Patient-Tailored Management of Multiple Sclerosis;Brain Sciences;2021-08-12
4. Digital Twins for Multiple Sclerosis;Frontiers in Immunology;2021-05-03
5. Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study;Therapeutic Advances in Chronic Disease;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3